- Home
- WST vs EBR Comparison
WST vs EBR Comparison
Compare WST & EBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WST
- EBR
- Stock Information
- Founded
- WST 1923
- EBR 1962
- Country
- WST United States
- EBR Brazil
- Employees
- WST N/A
- EBR N/A
- Industry
- WST Medical/Dental Instruments
- EBR Electric Utilities: Central
- Sector
- WST Health Care
- EBR Utilities
- Exchange
- WST Nasdaq
- EBR Nasdaq
- Market Cap
- WST 15.6B
- EBR 16.7B
- IPO Year
- WST N/A
- EBR N/A
- Fundamental
- Price
- WST $215.84
- EBR $7.23
- Analyst Decision
- WST Strong Buy
- EBR
- Analyst Count
- WST 6
- EBR 0
- Target Price
- WST $349.00
- EBR N/A
- AVG Volume (30 Days)
- WST 587.7K
- EBR 1.3M
- Earning Date
- WST 07-24-2025
- EBR 08-07-2025
- Dividend Yield
- WST 0.39%
- EBR 3.87%
- EPS Growth
- WST N/A
- EBR 124.86
- EPS
- WST 6.37
- EBR 0.75
- Revenue
- WST $2,895,800,000.00
- EBR $7,303,995,794.00
- Revenue This Year
- WST $3.38
- EBR $4.95
- Revenue Next Year
- WST $5.85
- EBR $10.06
- P/E Ratio
- WST $34.09
- EBR $9.95
- Revenue Growth
- WST N/A
- EBR 14.21
- 52 Week Low
- WST $187.43
- EBR $5.45
- 52 Week High
- WST $352.33
- EBR $7.83
- Technical
- Relative Strength Index (RSI)
- WST 48.07
- EBR 45.21
- Support Level
- WST $221.02
- EBR $7.36
- Resistance Level
- WST $230.27
- EBR $7.69
- Average True Range (ATR)
- WST 5.73
- EBR 0.13
- MACD
- WST -0.20
- EBR -0.00
- Stochastic Oscillator
- WST 40.05
- EBR 21.28
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
About EBR Centrais Electricas Brasileiras S A (Each representing one Common Share)
Centrais Eletricas Brasileiras SA is engaged in the generation, transmission, and commercialization of electricity in Brazil. The company operates a portfolio of wind, thermal, hydro, and nuclear power plants located throughout the country. Its segments are Generation which consists of the generation of electric energy and the sale of energy to distribution companies and free consumers, and commercialization; Transmission which consists of the transmission of electric energy; and Administration activities mainly represent the Company's cash management, the management of the compulsory loan, and the management of business in SPEs, and others.